Early research (Phase 1)WithdrawnNCT01320787What this trial is testing18-F-Fluoroacetate as PET Imaging AgentWho this might be right forBrain CancerBreast CancerProstate Cancer M.D. Anderson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05239143What this trial is testingP-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsWho this might be right forBreast CancerOvarian CancerNon Small Cell Lung Cancer+6 more Poseida Therapeutics, Inc. 180
Early research (Phase 1)Looking for participantsNCT06582017What this trial is testingSafety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaWho this might be right forOvarian CancerPancreas CancerUrothelial Carcinoma+6 more Nammi Therapeutics Inc 100
Early research (Phase 1)Ended earlyNCT04665921What this trial is testingSGN-STNV in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungHER2 Negative Breast NeoplasmsOvarian Neoplasms+9 more Seagen Inc. 111
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613What this trial is testingCediranib in Combination With Olaparib in Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more National Cancer Institute (NCI) 122
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Testing effectiveness (Phase 2)Study completedNCT01177397What this trial is testingStudy to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple MyelomaWho this might be right forMultiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more Celgene 226
Testing effectiveness (Phase 2)Study completedNCT02199418What this trial is testingAddition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast CancerWho this might be right forTubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more RenJi Hospital 132
Early research (Phase 1)Active Not RecruitingNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)Study completedNCT00002475What this trial is testingCyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerWho this might be right forBreast CancerColorectal CancerKidney Cancer+3 more St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)Study completedNCT02643303What this trial is testingTremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersWho this might be right forHead and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more Ludwig Institute for Cancer Research 58
Early research (Phase 1)UnknownNCT04764084What this trial is testingNiraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid TumorsWho this might be right forHER2-negative Breast CancerGastric AdenocarcinomaCholangiocarcinoma+1 more Peking University Cancer Hospital & Institute 52
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Early research (Phase 1)UnknownNCT05311618What this trial is testingStudy of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerBreast CancerGastric Cancer+13 more NGM Biopharmaceuticals, Inc 71
Early research (Phase 1)Study completedNCT03071757What this trial is testingThe Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors Cancer AbbVie 139
Early research (Phase 1)Study completedNCT01183663What this trial is testingLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)Who this might be right forAdvanced Cancers M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT02527434What this trial is testingStudy of Tremelimumab in Patients With Advanced Solid TumorsWho this might be right forUrothelial Bladder CancerTriple-negative Breast CancerPancreatic Ductal Adenocarcinoma AstraZeneca 64
Early research (Phase 1)Ended earlyNCT06299163What this trial is testingNM32-2668 in Adult Patients With Selected Advanced Solid TumorsWho this might be right forOvarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more Numab Therapeutics AG 11